Literature DB >> 16208007

Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy.

Joseph F Perz1, Allen S Craig, Charles W Stratton, Stanley J Bodner, Walter E Phillips, William Schaffner.   

Abstract

Pseudomonas putida bloodstream infections were reported in two preterm neonates from a special care nursery. An unopened container of preservative-free heparin flush, compounded several weeks earlier in the hospital pharmacy and from the same batch that was administered to the patients, grew P. putida with a pulsed-field gel electrophoresis (PFGE) pattern identical to that of the patients' isolates. Intrinsic contamination was ruled out by the absence of similar reports from other hospitals and by sterility testing of unopened stock solutions. We investigated the in vitro persistence of P. putida in heparinized saline: even under refrigerated conditions, inocula of 10(2) and 10(3) CFU/ml exhibited growth at 21 and 35 days, respectively. These findings highlight the need for compliance with current standards of aseptic technique and quality assurance during the preparation of compounded sterile products.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208007      PMCID: PMC1248510          DOI: 10.1128/JCM.43.10.5316-5318.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  ASHP guidelines on quality assurance for pharmacy-prepared sterile products. American Society of Health System Pharmacists.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2000-06-15       Impact factor: 2.637

2.  National survey of quality assurance activities for pharmacy-compounded sterile preparations.

Authors:  Aisha M Morris; Philip J Schneider; Craig A Pedersen; Jay M Mirtallo
Journal:  Am J Health Syst Pharm       Date:  2003-12-15       Impact factor: 2.637

3.  Sterile compounding in hospital pharmacies.

Authors:  C Richard Talley
Journal:  Am J Health Syst Pharm       Date:  2003-12-15       Impact factor: 2.637

4.  USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.

Authors:  Eric S Kastango; Brian D Bradshaw
Journal:  Am J Health Syst Pharm       Date:  2004-09-15       Impact factor: 2.637

5.  Needed: serious attention to sterile products.

Authors:  C E Myers
Journal:  Am J Health Syst Pharm       Date:  1996-11-01       Impact factor: 2.637

6.  Reported contamination of heparin sodium with Pseudomonas putida.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-02-28       Impact factor: 17.586

7.  Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants.

Authors:  D S Jardine; K Rogers
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

8.  ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1993-11

9.  Pseudomonas bloodstream infections associated with a heparin/saline flush--Missouri, New York, Texas, and Michigan, 2004-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-25       Impact factor: 17.586

10.  Outbreak of Pseudomonas putida bacteraemia in a neonatal intensive care unit.

Authors:  O Bouallègue; R Mzoughi; F-X Weill; N Mahdhaoui; Y Ben Salem; H Sboui; F Grimont; P A D Grimont
Journal:  J Hosp Infect       Date:  2004-05       Impact factor: 3.926

View more
  14 in total

1.  Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.

Authors:  Travis Warner; Cesilia Nishi; Ryan Checkowski; Kevin W Hall
Journal:  Can J Hosp Pharm       Date:  2009-03

2.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

3.  Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Authors:  Alice S Weissfeld; Riya Augustin Joseph; Theresa V Le; Ernest A Trevino; M Frances Schaeffer; Paula H Vance
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

Review 4.  Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Authors:  Alice S Weissfeld
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

5.  Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species.

Authors:  Jinki Yeom; James A Imlay; Woojun Park
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

Review 6.  U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Authors:  Nadine Shehab; Megan N Brown; Alexander J Kallen; Joseph F Perz
Journal:  J Patient Saf       Date:  2018-09       Impact factor: 2.844

7.  Analysis of 72-hour sterility of common pediatric continuous intravenous infusions.

Authors:  Christina C Piro; Jennifer Davis; Arlesia Frelix; Alison G Grisso; Julie Sinclair-Pingel; Harold Willingham; Lorianne Wright; Amy L Potts
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

8.  Plasmid-mediated quinolone resistance in pseudomonas putida isolates from imported shrimp.

Authors:  Quynh T Tran; Mohamed S Nawaz; Joanna Deck; Kiet T Nguyen; Carl E Cerniglia
Journal:  Appl Environ Microbiol       Date:  2010-12-30       Impact factor: 4.792

9.  Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality.

Authors:  Seong Eun Kim; Seong-Hwan Park; Hyun Bum Park; Kyung-Hwa Park; Su-Hyun Kim; Sook-In Jung; Jong-Hee Shin; Hee-Chang Jang; Seung Ji Kang
Journal:  Chonnam Med J       Date:  2012-08-24

10.  Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl.

Authors:  Lisa L Maragakis; Romanee Chaiwarith; Arjun Srinivasan; Francesca J Torriani; Edina Avdic; Andrew Lee; Tracy R Ross; Karen C Carroll; Trish M Perl
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.